Literature DB >> 12172722

Implications of prion diseases for neurosurgery.

Thomas Blättler1.   

Abstract

Prion diseases comprise a group of diseases characterised by transmissibility, spongiosis, gliosis, neuronal loss, and accumulation of an abnormally folded membrane protein, PrP(Sc). Infectivity resists almost all chemical and physical processes that inactivate conventional viruses, whereas protein extraction abolishes infectivity. This fact is of great importance to surgery, especially neurosurgery, since conventional cleaning of surgical instruments does not abolish infectivity. As a matter of consequence, few cases of putative neurosurgical transmission of Creutzfeldt-Jakob disease (CJD) have been reported. Putative transmission has also been reported through the use of lyophilised dura mater, corneal transplants, and cortical EEG electrodes. Moreover, many children have been infected with CJD by intramuscular or subcutaneous injection of cadaveric pituitary-derived human growth hormone. In recent years, the occurrence of bovine spongiform encephalopathy and consequently new variant Creutzfeldt-Jakob disease has increased concerns that prions also may contaminate the blood supply. Animal models of prion disease can help the understanding of how prions spread within an infected organism and the identification of which tissues may be contagious. Taking the right precautions against iatrogenic transmission requires knowledge about the nature of prion diseases - not only for the persons working out the directives but also for health care workers potentially involved with CJD patients or contaminated specimens.

Entities:  

Mesh:

Year:  2002        PMID: 12172722     DOI: 10.1007/s101430100170

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  6 in total

Review 1.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

2.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

3.  Clinical experience with a novel bovine collagen dura mater substitute.

Authors:  Bruno Silva Costa; George de Albuquerque Cavalcanti-Mendes; Marcelo Sartori de Abreu; Atos Alves de Sousa
Journal:  Asian J Neurosurg       Date:  2010-07

4.  A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004.

Authors:  Jessica Ruegger; Katharina Stoeck; Lorenz Amsler; Thomas Blaettler; Marcel Zwahlen; Adriano Aguzzi; Markus Glatzel; Klaus Hess; Tobias Eckert
Journal:  BMC Public Health       Date:  2009-01-14       Impact factor: 3.295

5.  A novel equine-derived pericardium membrane for dural repair: A preliminary, short-term investigation.

Authors:  Roberto Centonze; Emiliano Agostini; Samantha Massaccesi; Stefano Toninelli; Letterio Morabito
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep

6.  Prion diseases are undercompulsory notification in Brazil: Surveillance of cases evaluated by biochemicaland/or genetic markers from 2005 to 2007.

Authors:  Vilma Regina Martins; Hélio Rodrigues Gomes; Leila Chimelli; Sergio Rosemberg; Michele Christine Landemberger
Journal:  Dement Neuropsychol       Date:  2007 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.